Description
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research.
Cat.No
A090
Name
Emicizumab
Chemical Properties
CAS
1610943-06-0
Synonyms
Emicizumab;Research Grade Emicizumab (DHB87901);Emicizumab (anti-Factor IX);Emicizumab (anti-Factor IX);Emicizumab (anti-Factor IX);ACE 910|||RO 5534262;ACE 910|||RO 5534262;ACE 910|||RO 5534262
pH value
Corresponds to reference standard: PASS
Non-reduced CE-SDS
>95%
SEC-HPLC
>95%
Isoelectric Point
Corresponds to reference standard Corresponds to reference standard: PASS
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard: PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
